Contributions to collective works (2)
  1. 1. Ando, K., Laborde, Q., Brion, J. P., & Duyckaerts, C. (2018). 3-D imaging in post-mortem human brain with CLARITY and CUBIC. In I. Huitinga & M. Webster (Eds.), 3D imaging in the postmortem human brain with CLARITY and CUBIC, Vol. 150. Brain Banking in Neurologic and Psychiatric Diseases (pp. 303-317). Elsevier.(Handbook of Clinical Neurology). doi:10.1016/b978-0-444-63639-3.00021-9
  2. 2. Ando, K. (2014). Alzheimer risk factor, PICALM is involved in tau pathology in Alzheimer and other tauopathies. In Psychiatry Today (p. 15). Tokyo, Japan: Haruyoshi Kato.
    3.   Peer-reviewed journal articles (50)
  3. 1. Ramos, A. R., Bregni, G., Gillet, N., Ando, K., Bodart, C., Vercauteren Drubbel, A., Descampe, L., Moresi, F., Bisteau, X., Verheye, Q., Pirard, S., Erneux, C., & Beck, B. (2025). SHIP2–PLK1 crosstalk promotes sensitivity to dual inhibition in esophageal squamous cell carcinoma. Molecular cancer.
  4. 2. Kosa, A.-C., López Gutiérrez, L., Ando, K., Doeraene, E., Aydin, E., Lasri, H., Wathelet-Depauw, A., Pieters, K., Van Morckhoven, D., Imbault, V., Dubois, C., Bisteau, X., Stamatopoulos, B., Igoillo Esteve, M., Brion, J. P., & Leroy, K. (2025). Differential effects of age and sex on tau pathology propagation in the htau mouse model: a neuropathological and proteomic study. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(1), e70784. doi:doi.org/10.1002/alz.70784
  5. 3. Ando, K., Htut Thazin, M., Antonelli, E. M., Kosa, A.-C., López Gutiérrez, L., Quintanilla Sanchez, C., Aydin, E., Doeraene, E., Nagaraj, S., Ramos, A. R., Coulonval, K., Roger, P. P., Brion, J. P., & Leroy, K. (2025). Dysregulation of Inositol Polyphosphate 5-Phosphatase OCRL in Alzheimer’s Disease: Implications for Autophagy Dysfunction. International journal of molecular sciences, 26(12), 5827.
  6. 4. Ando, K., Kosa, A.-C., Mehadji, Y., Lasri, H., López Gutiérrez, L., Quintanilla Sanchez, C., Aydin, E., Doeraene, E., Wathelet-Depauw, A., Nagaraj, S., Brion, J. P., & Leroy, K. (2025). Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model. Biomolecules, 15(2), doi.org/10.3390/biom15020159, 159.
  7. 5. Nagaraj, S., Quintanilla Sanchez, C., Ando, K., López Gutiérrez, L., Doeraene, E., Kosa, A.-C., Aydin, E., Brion, J. P., & Leroy, K. (2024). Downregulation of hsa-miR-132 and has-miR129: non-coding RNA molecular signatures of Alzheimer's disease. Frontiers in Molecular Neuroscience, 17(2), 10.3389/fnmol.2024.1423340.
  8. 6. Ando, K., Küçükali, F., Doeraene, E., Nagaraj, S., Antonelli, E. M., Htut Thazin, M., Yilmaz, Z., Kosa, A.-C., López Gutiérrez, L., Quintanilla Sanchez, C., Aydin, E., Ramos, A. R., Mansour, S., Turbant, S., Schurmans, S., Sleegers, K., Erneux, C., Brion, J. P., & Leroy, K. (2024). Alteration of gene expression and protein solubility of the PI5- phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression. Acta Neuropathologica, 147(94), 10.1007/s00401-024-02745-7.
  9. 7. Ando, K., Nagaraj, S., Küçükali, F., De Fisenne, M.-A., Kosa, A.-C., Doeraene, E., López Gutiérrez, L., Brion, J. P., & Leroy, K. (2022). PICALM and Alzheimer’s Disease: An Update and Perspectives. Cells, 11(24), 3994. doi:10.3390/cells11243994
  10. 8. De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2022). Alzheimer PHF-tau aggregates do not spread tau pathology to the brain via the Retino-tectal projection after intraocular injection in male mouse models. Neurobiology of disease, 174, 105875. doi:10.1016/j.nbd.2022.105875
  11. 9. Ando, K., Erneux, C., Homa, M., Houben, S., De Fisenne, M.-A., Brion, J. P., & Leroy, K. (2021). Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease. Frontiers in Neuroscience, 15, 614855. doi:10.3389/fnins.2021.614855
  12. 10. Houben, S., Homa, M., Yilmaz, Z., Leroy, K., Brion, J. P., & Ando, K. (2021). Tau Pathology and Adult Hippocampal Neurogenesis: What Tau Mouse Models Tell us? Frontiers in neurology, 12, 610330. doi:10.3389/fneur.2021.610330
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next >>